TB Intensive Workshop

Date: April 9-12, 2019
Location: 225 Warren Street, 1st Floor Newark, NJ 07103

COURSE DESCRIPTION & OVERALL GOAL
This workshop for clinicians provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special populations. Topics include transmission and pathogenesis, diagnosis and treatment, drug resistance, TB-HIV co-infection, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.

AGENDA

WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospital Infection Control
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Settings
  • College or University Health Services
WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

OBJECTIVES
Upon completion of this workshop, participants should be better able to:

  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.
  • Interpret epidemiologic trends to better screen and treat groups who are at high risk for tuberculosis.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • Integrate current recommendations for the prevention and management of tuberculosis in children and adolescents.
  • Develop strategies for the care of TB patients with co-morbidities to ensure prompt diagnosis, integrated treatment, and effective management.
  • Apply the latest advances for assessing risk, testing and treating TB infection to prevent development of disease.

COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: http://www.cdc.gov/tb/education/corecurr/index.htm). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 1 month of the course.

CONTINUING EDUCATION INFORMATION

http://jointaccreditation.org/sites/default/files/Jointly%20Accredited%20Provider%20TM.jpgIn support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 23.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 23.75 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
Please note, we are no longer accepting new applicants as we have reached full capacity for this course.

CANCELLATION INFORMATION
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Shwata Suresh Kumar at
ss2980@rutgers.edu. 

FACULTY

E. Jane Carter, MD
Associate Professor of Medicine
Brown University

Henry Fraimow, MD
Assistant Professor of Medicine
Cooper Medical School of Rowan University

Dianne Fyffe-Washington, RN, BSN
Assistant Nurse Manager, Lattimore Practice
Global Tuberculosis Institute

Scott Heysell, MD
Assistant Professor of Medicine
University of Virginia

Barry Kreiswirth, PhD
Director, TB Center
Public Health Research Institute

Alfred Lardizabal, MD
Executive Director
Global Tuberculosis Institute

George McSherry, MD
Chief, Pediatric Infectious Disease Division
Penn State Children's Hospital

Dona Miller
Public Health Representative, Lattimore Practice
Global Tuberculosis Institute

Navaneeth Narayanan, PharmD
Clinical Assistant Professor
Rutgers University, Ernest Mario School of Pharmacy

Diana Nilsen, MD
Director of Medical Affairs, Bureau of TB Control
New York City Department of Health and Mental Hygiene

Amee Patrawalla, MD
Medical Director
Global Tuberculosis Institute

Lynn Sosa, MD
Deputy State Epidemiologist
Connecticut Department of Public Health

James Sunstrum, MD
Clinical Associate Professor
Wayne State University School of Medicine

Christopher Vinnard, MD
Associate Professor
Rutgers New Jersey Medical School

Mark Wolman, MPH
Program Manager, TB Control
Global Tuberculosis Institute

Patricia Woods, RN, MSN
Nurse Manager, Lattimore Practice
Global Tuberculosis Institute



 

PLANNING COMMITTEE

Anita Khilall, MPH - Activity Director
Program Director, Education & Training
Global Tuberculosis Institute

Alfred Lardizabal, MD
Executive Director
Global Tuberculosis Institute


Shwata Suresh Kumar, MPH
Health Educator
Global Tuberculosis Institute

Patricia Woods, RN, MSN
Nurse Manager, Lattimore Practice
Global Tuberculosis Institute